Clinical trials in progression of chronic renal failure.
作者信息
Striker G E, Klahr S
机构信息
Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Adv Intern Med. 1997;42:555-95.
PMID:9048130
Abstract
摘要
相似文献
1
Clinical trials in progression of chronic renal failure.慢性肾衰竭进展的临床试验。
Adv Intern Med. 1997;42:555-95.
2
Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?肾素-血管紧张素系统阻断与肾病：为何受到质疑，是否应受质疑？
Clin J Am Soc Nephrol. 2006 Sep;1(5):1046-8. doi: 10.2215/CJN.00540206. Epub 2006 Jul 19.
3
Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?糖尿病和非糖尿病慢性肾脏病中通过阻断肾素-血管紧张素-醛固酮系统实现的肾脏保护作用。肾内血管紧张素转换酶活性在治疗抵抗中的具体作用？
Minerva Med. 2004 Oct;95(5):395-409.
4
Preserving the diabetic kidney.
J Fam Pract. 1998 Jan;46(1):21-7.
5
6
7
[Angiotensin-converting enzyme inhibition and progressing chronic nephropathy].血管紧张素转换酶抑制与慢性肾病进展
Ugeskr Laeger. 1997 Nov 24;159(48):7121-3.
8
ACE inhibitors as a shield against diabetic nephropathy.血管紧张素转换酶抑制剂作为预防糖尿病肾病的一种保护措施。
Arch Intern Med. 1996 Feb 12;156(3):239-40.
9
Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease.
J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S66-70.
10
[ACE inhibitors and AT-II antagonists--do they protect against renal disease?].[血管紧张素转换酶抑制剂和血管紧张素II拮抗剂——它们能预防肾脏疾病吗？]
Ugeskr Laeger. 2006 Apr 10;168(15):1564; author reply1564-5.
Zotero 插件